Products
Preparation registered in Ukraine
Serhienko A., Podsadochnaia I., Sehin V., Serhienko L.
Stifimol efficacy in obesity treatment
The study evaluated the efficacy of Stifimol (produced by PC “Kyiv Vitamin Factory”) in treatment of 42 patients with primary I grade obesity together with basic therapy (diet). Stifimol is a highly effective drug in treatment of patients with primary I grade obesity. It was concluded that designation of Stifimol for 3 months in patients with primary I grade obesity leads to effective reduction in body mass index and, respectively, of body weight. It is established that the appointment of Stifimol was accompanied by a decrease in appetite. Course designation of Stifimol is accompanied by a decrease of insulin resistance values and improvement of lipid metabolism. Stifimol is well tolerated, no side effects are observed. Our studies suggest the absence of “withdrawal symptoms” in examined patients.
Key words: obesity, body mass index, insulin resistance, lipid metabolism, Stifimol.